|
Market Closed -
London S.E.
11:35:08 2026-08-25 am EDT
|
5-day change | 1st Jan Change | ||
| 1,640.00 GBX | +0.43% |
|
+0.06% | +5.81% |
| 04:35am | Citigroup says 'buy' Next, UBS raises Drax | AN |
| Aug. 21 | Hikma Pharmaceuticals: H1 profitability beat; but needs internal biosimilars for sustained re-rating | ![]() |
| Market Cap | 4.7B 4.03B 3.78B 3.45B 6.51B 448B 6.58B 44.55B 17.34B 226B 17.66B 17.28B 749B | P/E 2026 * |
12.2x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.17B 5.29B 4.96B 4.53B 8.54B 588B 8.63B 58.46B 22.76B 297B 23.18B 22.67B 983B | EV / Sales 2026 * |
1.78x | EV / Sales 2027 * | 1.67x |
| Free-Float |
63.21% | Yield 2026 * |
3.86% | Yield 2027 * | 4.09% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | +0.15% | ||
| 1 week | +0.06% | ||
| Current month | +3.47% | ||
| 1 month | +3.67% | ||
| 3 months | +12.41% | ||
| 6 months | -0.79% | ||
| Current year | +5.81% |
| 1 week | 1,607.8 | 1,669 | |
| 1 month | 1,563 | 1,755 | |
| Current year | 1,187 | 1,762 | |
| 1 year | 1,187 | 1,865 | |
| 3 years | 1,187 | 2,360 | |
| 5 years | 1,174.5 | 2,625 | |
| 10 years | 814.2 | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 2025-11-30 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 2026-02-25 |
| Chief Tech/Sci/R&D Officer | 64 | 2026-02-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2005-10-13 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 2025-12-14 |
Said Darwazah
CHM | Chairman | 69 | 2014-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/19/25 | Buy | Director | 100,000 | 0.0451% | ||
| 11/11/25 | Buy | Chief Executive Officer | 70,000 | 0.0315% | ||
| 11/11/25 | Buy | Chief Executive Officer | 100,000 | 0.0451% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.43% | +0.06% | -10.68% | -21.76% | 4.69B | ||
| -1.06% | +0.65% | +77.42% | +122.82% | 1,111B | ||
| +0.53% | +0.75% | +53.10% | +64.29% | 658B | ||
| +0.48% | +2.65% | +28.06% | +81.19% | 467B | ||
| +0.92% | +4.97% | +42.94% | +43.69% | 369B | ||
| +1.25% | +4.00% | +25.87% | +42.82% | 301B | ||
| +3.02% | +7.92% | +4.24% | +16.06% | 256B | ||
| -0.36% | +3.99% | +53.31% | +72.49% | 240B | ||
| +2.86% | +5.27% | -15.42% | -52.34% | 207B | ||
| +1.38% | +3.72% | +30.33% | +93.56% | 182B | ||
| Average | +0.95% | +4.01% | +28.92% | +46.28% | 379.57B | |
| Weighted average by Cap. | +0.62% | +4.67% | +45.81% | +72.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 2.97B 2.78B 2.54B 4.79B 330B 4.84B 32.79B 12.77B 167B 13B 12.72B 552B | 3.6B 3.09B 2.89B 2.64B 4.99B 343B 5.03B 34.11B 13.28B 173B 13.52B 13.23B 574B |
| Net income | 412M 353M 331M 302M 571M 39.3B 576M 3.9B 1.52B 19.83B 1.55B 1.51B 65.66B | 453M 389M 364M 333M 628M 43.23B 634M 4.29B 1.67B 21.81B 1.7B 1.67B 72.22B |
| Net Debt | 1.47B 1.26B 1.18B 1.08B 2.03B 140B 2.05B 13.91B 5.42B 70.65B 5.51B 5.39B 234B | 1.29B 1.11B 1.04B 949M 1.79B 123B 1.81B 12.25B 4.77B 62.21B 4.86B 4.75B 206B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | GBX 1,640.00 | +0.43% | 308,611 |
| 26-08-24 | GBX 1,633.00 | -0.18% | 680,937 |
| 26-08-21 | GBX 1,636.00 | +0.74% | 511,578 |
| 26-08-20 | GBX 1,624.00 | -2.05% | 458,598 |
| 26-08-19 | GBX 1,658.00 | +0.36% | 567,937 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions




















